SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+6.86%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$198M
AUM Growth
+$198M
(-1.4%)
Cap. Flow
-$11.4M
Cap. Flow
% of AUM
-5.75%
Top 10 Holdings %
Top 10 Hldgs %
37.09%
Holding
72
New
13
Increased
19
Reduced
13
Closed
21
Top Buys
| 1 |
Molina Healthcare
MOH
|
$4.67M |
| 2 |
Humana
HUM
|
$4.14M |
| 3 |
Eli Lilly
LLY
|
$4.01M |
| 4 |
Integra LifeSciences
IART
|
$3.72M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$3.68M |
Top Sells
| 1 |
Universal Health Services
UHS
|
$6.04M |
| 2 |
Stryker
SYK
|
$5.99M |
| 3 |
HCA Healthcare
HCA
|
$5.46M |
| 4 |
Tenet Healthcare
THC
|
$4.84M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
$4.17M |
Sector Composition
| 1 | Healthcare | 91.46% |
| 2 | Financials | 2.33% |
| 3 | Energy | 0.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Integra LifeSciences
IART
$1.18B
| $3.72M | 1.87% |
+45,000
| New | +$3.72M |
|
|
GWPH
27
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.68M | 1.85% |
27,700
-2,300
| -8% | -$305K |
|
28
AbbVie
ABBV
$372B
| $3.47M | 1.75% |
+55,000
| New | +$3.47M |
|
29
Agilent Technologies
A
$35.7B
| $3.3M | 1.66% |
70,000
-30,076
| -30% | -$1.42M |
|
|
IPXL
30
DELISTED
Impax Laboratories, Inc.
IPXL
| $3.08M | 1.55% |
+130,000
| New | +$3.08M |
|
|
SHPG
31
DELISTED
Shire pic
SHPG
| $2.91M | 1.47% |
15,000
-10,000
| -40% | -$1.94M |
|
|
WMGI
32
DELISTED
Wright Medical Group Inc
WMGI
| $2.82M | 1.42% |
115,000
-35,000
| -23% | -$859K |
|
33
Illumina
ILMN
$15.8B
| $2.73M | 1.37% |
+15,000
| New | +$2.73M |
|
34
Smith & Nephew
SNN
$16.3B
| $2.46M | 1.24% |
+75,000
| New | +$2.46M |
|
35
Revvity
RVTY
$10.5B
| $2.24M | 1.13% |
40,000
-10,000
| -20% | -$561K |
|
36
Chemed
CHE
$6.67B
| $2.12M | 1.07% |
15,000
-10,000
| -40% | -$1.41M |
|
37
Acadia Pharmaceuticals
ACAD
$4.38B
| $2.09M | 1.05% |
65,577
+8,077
| +14% | +$257K |
|
38
Zoetis
ZTS
$69.3B
| $1.82M | 0.92% |
+35,000
| New | +$1.82M |
|
39
Fresenius Medical Care
FMS
$15.1B
| $1.75M | 0.88% |
+40,000
| New | +$1.75M |
|
|
LHCG
40
DELISTED
LHC Group LLC
LHCG
| $1.66M | 0.84% |
45,000
-45,000
| -50% | -$1.66M |
|
|
AMED
41
DELISTED
Amedisys
AMED
| $1.42M | 0.72% |
30,000
-30,000
| -50% | -$1.42M |
|
42
Dr. Reddy's Laboratories
RDY
$11.8B
| $1.39M | 0.7% |
+30,000
| New | +$1.39M |
|
|
BLUE
43
DELISTED
bluebird bio
BLUE
| $1.2M | 0.6% |
17,669
-2,331
| -12% | -$158K |
|
|
JUNO
44
DELISTED
Juno Therapeutics, Inc.
JUNO
| $1.05M | 0.53% |
+35,000
| New | +$1.05M |
|
|
KITE
45
DELISTED
Kite Pharma, Inc.
KITE
| $838K | 0.42% |
15,000
-5,000
| -25% | -$279K |
|
46
Neurocrine Biosciences
NBIX
$13.8B
| $790K | 0.4% |
+15,600
| New | +$790K |
|
47
AMN Healthcare
AMN
$796M
| – | – |
-40,000
| Closed | -$1.6M |
|
48
Bristol-Myers Squibb
BMY
$96B
| – | – |
-55,000
| Closed | -$4.05M |
|
49
Community Health Systems
CYH
$387M
| – | – |
-150,000
| Closed | -$1.81M |
|
50
Quest Diagnostics
DGX
$20.3B
| – | – |
-45,000
| Closed | -$3.66M |
|